SCHEMBL6062586

SCHEMBL6062586

CCCCCCCC(O)c1ccccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.51
ADRB1 P08588 2/20 0.51
AOC3 Q16853 1/20 0.51
CYP2D6 P10635 2/20 0.50
NFKB1 P19838 1/20 0.50
HIF1A Q16665 1/20 0.50
BLM P54132 1/20 0.49
PPARG P37231 4/20 0.47
CSNK1E P49674 1/20 0.44
PPARA Q07869 2/20 0.41
CASP1 P29466 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYSLTR2 Q9NS75 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23347622 0.98 ADRB2 (0.53) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL19646702 0.93 ADRB2 (0.54) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL6680491 0.93 ADRB2 (0.54) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL5693670 0.87 ADRB2 (0.56) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL6684286 0.82 ADRB2 (0.40) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL11861289 0.81 CYSLTR2 (0.43) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL11854685 0.81 CYSLTR2 (0.43) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL11851265 0.81 CYSLTR2 (0.43) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL15675138 0.81 CFD (0.47) ADRB2ADRB1AOC3CYP2D6NFKB1
SCHEMBL7471569 0.81 KDM4E (0.39) ADRB2ADRB1AOC3CYP2D6NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060167313-A1 Process for preparing encapsulated metalloporphyrin catalyst and process for oxidation of alcohols COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167313-A1 Process for preparing encapsulated metalloporphyrin catalyst and process for oxidation of alcohols ADH1A, ADH1C, ADH5 ADRB2 1009/4885ADRB1 718/4885AOC3 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.